Genetics of Appendix Cancer Study

Purpose

The GAP Study is a prospective cohort study designed to comprehensively investigate genetic variations that may contribute to cancer development among individuals diagnosed with appendix/appendiceal cancer who are ages 18+ years.

Conditions

  • Appendix Cancer
  • Appendiceal Cancer
  • Appendiceal Neoplasms
  • Appendiceal Mucinous Neoplasm
  • Appendiceal Adenocarcinoma
  • Appendiceal Carcinoid Tumor
  • Appendiceal Neoplasm Malignant Secondary
  • Appendix Adenocarcinoma
  • Appendix Mucinous Neoplasm
  • Appendix Tumor
  • Appendix Cancer Metastatic
  • Appendix NET
  • Low-Grade Appendix Mucinous Neoplasm
  • High Grade Appendix Mucinous Neoplasm
  • High Grade Appendix Mucinous Adenocarcinoma

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

GAP Social - Known diagnosis of appendix cancer in the United States - Mentally and physically able to consent and participate in the study GAP Vanderbilt - Known diagnosis of appendix cancer - Diagnosed by and/or consulting with a physician/clinical provider participating in the GAP Study - Mentally and physically able to consent and participate in the study GAP Parent - Biological parents (mother and/or father) of individuals actively participating in the GAP Study - Residing in the United States - Mentally and physically able to consent and participate in the study

Exclusion Criteria

  • Women pregnant at the time of consent - Prisoners - Unable to provide informed consent - Unable to read, write, or complete questionnaires in English

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
GAP Social Individuals ages 18+ years with an appendix cancer diagnosis in the United States.
  • Genetic: Genetic profiling
    Whole exome sequencing
  • Other: Retrospective tissue procurement
    Collection of archived fixed-formalin, paraffin-embedded (FFPE) primary appendix tumor tissues that were previously removed
GAP Vanderbilt Individuals ages 18+ years with an appendix cancer diagnosis seen at Vanderbilt.
  • Genetic: Genetic profiling
    Whole exome sequencing
  • Other: Retrospective tissue procurement
    Collection of archived fixed-formalin, paraffin-embedded (FFPE) primary appendix tumor tissues that were previously removed
GAP Parent Biological parents of active GAP (Social and Vanderbilt) Study participants.
  • Genetic: Genetic profiling
    Whole exome sequencing

Recruiting Locations

Vanderbilt-Ingram Cancer Center
Nashville, Tennessee 37232
Contact:
GAP Study Coordinator (Rebecca B.)
615-936-8544
gapcancerstudy@vumc.org

More Details

Status
Recruiting
Sponsor
Andreana Holowatyj, PhD, MSCI

Study Contact

GAP Study Coordinator (Rebecca B.)
615-936-8544
gapcancerstudy@vumc.org

Detailed Description

The Genetics of Appendix Cancer (GAP) Study aims to analyze hereditary factors, tumor characteristics and clinical features/outcomes among adults diagnosed with appendix cancer and their biological parents. Patients are recruited at any time after a diagnosis of appendix cancer and followed for up to 6 years after study enrollment. This cohort is enriched by robust biospecimens and data collections.